<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Hujoel MLA</submitter><funding>NIEHS NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>NIH HHS</funding><pubmed_abstract>Structural variants (SVs) comprise the largest genetic variants, altering from 50 base pairs to megabases of DNA. However, SVs have not been effectively ascertained in most genetic association studies, leaving a key gap in our understanding of human complex trait genetics. We ascertained protein-altering SVs from UK Biobank whole-exome sequencing data (&lt;i>n&lt;/i>=468,570) using haplotype-informed methods capable of detecting sub-exonic SVs and variation within segmental duplications. Incorporating SVs into analyses of rare variants predicted to cause gene loss-of-function (pLoF) identified 100 associations of pLoF variants with 41 quantitative traits. A low-frequency partial deletion of &lt;i>RGL3&lt;/i> exon 6 appeared to confer one of the strongest protective effects of gene LoF on hypertension </pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2023.06.07.544066</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10274781</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Hidden protein-altering variants influence diverse human phenotypes.</pubmed_title><pmcid>PMC10274781</pmcid><funding_grant_id>OT2 OD026548</funding_grant_id><funding_grant_id>OT2 OD025315</funding_grant_id><funding_grant_id>OT2 OD025337</funding_grant_id><funding_grant_id>OT2 OD026549</funding_grant_id><funding_grant_id>F31 HL154537</funding_grant_id><funding_grant_id>OT2 OD025277</funding_grant_id><funding_grant_id>OT2 OD025276</funding_grant_id><funding_grant_id>R56 HG006855</funding_grant_id><funding_grant_id>U24 OD023121</funding_grant_id><funding_grant_id>K25 HL150334</funding_grant_id><funding_grant_id>F32 HL160061</funding_grant_id><funding_grant_id>U24 OD023163</funding_grant_id><funding_grant_id>U2C OD023196</funding_grant_id><funding_grant_id>OT2 OD026555</funding_grant_id><funding_grant_id>OT2 OD026554</funding_grant_id><funding_grant_id>F31 MH124393</funding_grant_id><funding_grant_id>OT2 OD026557</funding_grant_id><funding_grant_id>OT2 OD026556</funding_grant_id><funding_grant_id>OT2 OD023205</funding_grant_id><funding_grant_id>OT2 OD023206</funding_grant_id><funding_grant_id>OT2 OD026551</funding_grant_id><funding_grant_id>OT2 OD026550</funding_grant_id><funding_grant_id>OT2 OD026553</funding_grant_id><funding_grant_id>OT2 OD026552</funding_grant_id><funding_grant_id>R01 HG006855</funding_grant_id><funding_grant_id>U24 OD023176</funding_grant_id><funding_grant_id>T32 HG002295</funding_grant_id><funding_grant_id>DP2 ES030554</funding_grant_id><pubmed_authors>Kamitaki N</pubmed_authors><pubmed_authors>Loh PR</pubmed_authors><pubmed_authors>Hujoel MLA</pubmed_authors><pubmed_authors>McCarroll SA</pubmed_authors><pubmed_authors>Mukamel RE</pubmed_authors><pubmed_authors>Terao C</pubmed_authors><pubmed_authors>Barton AR</pubmed_authors><pubmed_authors>Handsaker RE</pubmed_authors><pubmed_authors>Sherman MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hidden protein-altering variants influence diverse human phenotypes.</name><description>Structural variants (SVs) comprise the largest genetic variants, altering from 50 base pairs to megabases of DNA. However, SVs have not been effectively ascertained in most genetic association studies, leaving a key gap in our understanding of human complex trait genetics. We ascertained protein-altering SVs from UK Biobank whole-exome sequencing data (&lt;i>n&lt;/i>=468,570) using haplotype-informed methods capable of detecting sub-exonic SVs and variation within segmental duplications. Incorporating SVs into analyses of rare variants predicted to cause gene loss-of-function (pLoF) identified 100 associations of pLoF variants with 41 quantitative traits. A low-frequency partial deletion of &lt;i>RGL3&lt;/i> exon 6 appeared to confer one of the strongest protective effects of gene LoF on hypertension </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2026-04-08T15:34:03.368Z</modification><creation>2025-04-06T17:40:15.243Z</creation></dates><accession>S-EPMC10274781</accession><cross_references><pubmed>37333244</pubmed><doi>10.1101/2023.06.07.544066</doi></cross_references></HashMap>